Skip to content

Drug interactions

Letermovir + Rabeprazole

Severity: Minor

Letermovir and Rabeprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir inhibits CYP3A4 but also induces CYP2C19 and CYP2C9, so its effect on PPIs is mixed. Rabeprazole is mainly cleared non-enzymatically, so large changes in exposure are not expected.

What this interaction means in plain words

Letermovir and Rabeprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Letermovir belongs to Anti Virals; Rabeprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Letermovir modulates CYP3A4 and CYP2C19, minor routes for rabeprazole.

What to do

No empiric dose change is needed. Monitor for reduced acid suppression or PPI adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Rabeprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Rabeprazole?

MediHelp rates the interaction as minor. Letermovir and Rabeprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir inhibits CYP3A4 but also induces CYP2C19 and CYP2C9, so its effect on PPIs is mixed. Rabeprazole is mainly cleared non-enzymatically, so large changes in exposure are not expected.

How serious is the interaction between Letermovir and Rabeprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric dose change is needed. Monitor for reduced acid suppression or PPI adverse effects.

What other medicines interact with Rabeprazole?

MediHelp also lists interactions of Rabeprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Rabeprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in